RT @paomorejon: 🚨A pesar de la evidencia, sólo 1% tiene dosis objetivo🚨 #InsuficienciaCardiaca •Una década del IMPROVE-HF, poco ha cambiad…
RT @JACCJournals: Are we missing the boat when it comes to using guideline HFrEF meds? https://t.co/9rbFCylt6Q #JACC @UCLAHealth @gcfmd @…
RT @JACCJournals: Are we missing the boat when it comes to using guideline HFrEF meds? https://t.co/9rbFCylt6Q #JACC @UCLAHealth @gcfmd @…
RT @JACCJournals: Are we missing the boat when it comes to using guideline HFrEF meds? https://t.co/9rbFCylt6Q #JACC @UCLAHealth @gcfmd @…
Encore une étude qui montre que les patients ambulatoires souffrant d'#InsuffisanceCardiaque 1/ n'ont pas les molécules recommandées 2/ quand ils ont les molécules, ils n'ont pas bonnes doses c'est aux US, mais pas de raison que ce soit mieux en France. h
RT @paomorejon: 🚨A pesar de la evidencia, sólo 1% tiene dosis objetivo🚨 #InsuficienciaCardiaca •Una década del IMPROVE-HF, poco ha cambiad…
RT @paomorejon: 🚨A pesar de la evidencia, sólo 1% tiene dosis objetivo🚨 #InsuficienciaCardiaca •Una década del IMPROVE-HF, poco ha cambiad…
RT @paomorejon: 🚨A pesar de la evidencia, sólo 1% tiene dosis objetivo🚨 #InsuficienciaCardiaca •Una década del IMPROVE-HF, poco ha cambiad…
RT @paomorejon: 🚨A pesar de la evidencia, sólo 1% tiene dosis objetivo🚨 #InsuficienciaCardiaca •Una década del IMPROVE-HF, poco ha cambiad…
RT @paomorejon: 🚨A pesar de la evidencia, sólo 1% tiene dosis objetivo🚨 #InsuficienciaCardiaca •Una década del IMPROVE-HF, poco ha cambiad…
RT @JACCJournals: Are we missing the boat when it comes to using guideline HFrEF meds? https://t.co/9rbFCylt6Q #JACC @UCLAHealth @gcfmd @…
RT @paomorejon: 🚨A pesar de la evidencia, sólo 1% tiene dosis objetivo🚨 #InsuficienciaCardiaca •Una década del IMPROVE-HF, poco ha cambiad…
RT @ATRIUMRx: Disconcerting results from CHAMP-HF: in patients with HFrEF (and no contraindications to therapies), 27%, 33%, and 67% were…
RT @JACCJournals: Are we missing the boat when it comes to using guideline HFrEF meds? https://t.co/9rbFCylt6Q #JACC @UCLAHealth @gcfmd @…
RT @gcfmd: Vital opportunity to improve use and dosing of GDMT for HFrEF. Medical Therapy for Heart Failure With Reduced Ejection Fraction…
We have found the same in our local population and are working on novel ways to address and improve achieving GDMT in our HFrEF patients, data to come! Hoping to further address what to do with our elderly patients with HFrEF in particular https://t.co/M0h
RT @paomorejon: 🚨A pesar de la evidencia, sólo 1% tiene dosis objetivo🚨 #InsuficienciaCardiaca •Una década del IMPROVE-HF, poco ha cambiad…
RT @Sbarrerab: Medical Tx for HF with Reduced EF (CHAMP-HF Registry) https://t.co/EwNe95JfdI https://t.co/LWKUNpOypf
RT @gcfmd: Vital opportunity to improve use and dosing of GDMT for HFrEF. Medical Therapy for Heart Failure With Reduced Ejection Fraction…
RT @MosiB: Room for improvement. In this analysis, only 1% of eligible heart failure patients received target doses of guideline indicated…
RT @paomorejon: 🚨A pesar de la evidencia, sólo 1% tiene dosis objetivo🚨 #InsuficienciaCardiaca •Una década del IMPROVE-HF, poco ha cambiad…
RT @paomorejon: 🚨A pesar de la evidencia, sólo 1% tiene dosis objetivo🚨 #InsuficienciaCardiaca •Una década del IMPROVE-HF, poco ha cambiad…
RT @paomorejon: 🚨A pesar de la evidencia, sólo 1% tiene dosis objetivo🚨 #InsuficienciaCardiaca •Una década del IMPROVE-HF, poco ha cambiad…
RT @SJGreene_md: In current US outpatient practice, there remain major gaps in use & dosing of proven #HFrEF medications. An important oppo…
RT @DrWillWatson: Here's a surprise, we suck at goal directed therapy for #HeartFailure and even more at getting it to the right dose https…
RT @DrWillWatson: Here's a surprise, we suck at goal directed therapy for #HeartFailure and even more at getting it to the right dose https…
RT @paomorejon: 🚨A pesar de la evidencia, sólo 1% tiene dosis objetivo🚨 #InsuficienciaCardiaca •Una década del IMPROVE-HF, poco ha cambiad…
Here's a surprise, we suck at goal directed therapy for #HeartFailure and even more at getting it to the right dose https://t.co/cEZPt3Yyst - what is the answer? Better monitoring to improve clinicans' confidence that they won't worsen their patients? #car
RT @JACCJournals: Are we missing the boat when it comes to using guideline HFrEF meds? https://t.co/9rbFCylt6Q #JACC @UCLAHealth @gcfmd @…
RT @JACCJournals: Are we missing the boat when it comes to using guideline HFrEF meds? https://t.co/9rbFCylt6Q #JACC @UCLAHealth @gcfmd @…
RT @paomorejon: 🚨A pesar de la evidencia, sólo 1% tiene dosis objetivo🚨 #InsuficienciaCardiaca •Una década del IMPROVE-HF, poco ha cambiad…
OMT should mean Optimal medical therapy, not Occasionally Might Try. (I will try harder) https://t.co/4Ujr4dBKCm
RT @JACCJournals: Are we missing the boat when it comes to using guideline HFrEF meds? https://t.co/9rbFCylt6Q #JACC @UCLAHealth @gcfmd @…
RT @paomorejon: 🚨A pesar de la evidencia, sólo 1% tiene dosis objetivo🚨 #InsuficienciaCardiaca •Una década del IMPROVE-HF, poco ha cambiad…
We certainly are for MR anatgonists as previously reported & time for change? https://t.co/dhhRRWKHVl
RT @JACCJournals: Are we missing the boat when it comes to using guideline HFrEF meds? https://t.co/9rbFCylt6Q #JACC @UCLAHealth @gcfmd @…
RT @SJGreene_md: In current US outpatient practice, there remain major gaps in use & dosing of proven #HFrEF medications. An important oppo…
RT @MosiB: Room for improvement. In this analysis, only 1% of eligible heart failure patients received target doses of guideline indicated…
RT @MosiB: Room for improvement. In this analysis, only 1% of eligible heart failure patients received target doses of guideline indicated…
RT @JACCJournals: Are we missing the boat when it comes to using guideline HFrEF meds? https://t.co/9rbFCylt6Q #JACC @UCLAHealth @gcfmd @…
RT @paomorejon: 🚨A pesar de la evidencia, sólo 1% tiene dosis objetivo🚨 #InsuficienciaCardiaca •Una década del IMPROVE-HF, poco ha cambiad…
RT @gcfmd: Vital opportunity to improve use and dosing of GDMT for HFrEF. Medical Therapy for Heart Failure With Reduced Ejection Fraction…
RT @JACCJournals: Are we missing the boat when it comes to using guideline HFrEF meds? https://t.co/9rbFCylt6Q #JACC @UCLAHealth @gcfmd @…
RT @paomorejon: 🚨A pesar de la evidencia, sólo 1% tiene dosis objetivo🚨 #InsuficienciaCardiaca •Una década del IMPROVE-HF, poco ha cambiad…
RT @JACCJournals: Are we missing the boat when it comes to using guideline HFrEF meds? https://t.co/9rbFCylt6Q #JACC @UCLAHealth @gcfmd @…
RT @paomorejon: 🚨A pesar de la evidencia, sólo 1% tiene dosis objetivo🚨 #InsuficienciaCardiaca •Una década del IMPROVE-HF, poco ha cambiad…
RT @paomorejon: 🚨A pesar de la evidencia, sólo 1% tiene dosis objetivo🚨 #InsuficienciaCardiaca •Una década del IMPROVE-HF, poco ha cambiad…
RT @paomorejon: 🚨A pesar de la evidencia, sólo 1% tiene dosis objetivo🚨 #InsuficienciaCardiaca •Una década del IMPROVE-HF, poco ha cambiad…
RT @JACCJournals: Are we missing the boat when it comes to using guideline HFrEF meds? https://t.co/9rbFCylt6Q #JACC @UCLAHealth @gcfmd @…
🚨A pesar de la evidencia, sólo 1% tiene dosis objetivo🚨 #InsuficienciaCardiaca •Una década del IMPROVE-HF, poco ha cambiado 🔛 bajas dosis ¿Por qué insistimos en no usar fármacos o hacerlo en bajas dosis? •Seguimiento inadecuado⁉️ #FOAMed #Cardioed https:
RT @JACCJournals: Are we missing the boat when it comes to using guideline HFrEF meds? https://t.co/9rbFCylt6Q #JACC @UCLAHealth @gcfmd @…
Room for improvement. In this analysis, only 1% of eligible heart failure patients received target doses of guideline indicated medications https://t.co/hSTqyqHvZY
RT @gcfmd: Vital opportunity to improve use and dosing of GDMT for HFrEF. Medical Therapy for Heart Failure With Reduced Ejection Fraction…
RT @gcfmd: Vital opportunity to improve use and dosing of GDMT for HFrEF. Medical Therapy for Heart Failure With Reduced Ejection Fraction…
RT @JACCJournals: Are we missing the boat when it comes to using guideline HFrEF meds? https://t.co/9rbFCylt6Q #JACC @UCLAHealth @gcfmd @…
RT @JTLLERGO: Significant gaps in use and dose of guideline-directed medical therapy in a contemporary outpatient HFrEF registry (The CHAMP…
RT @SJGreene_md: In current US outpatient practice, there remain major gaps in use & dosing of proven #HFrEF medications. An important oppo…
RT @JACCJournals: Are we missing the boat when it comes to using guideline HFrEF meds? https://t.co/9rbFCylt6Q #JACC @UCLAHealth @gcfmd @…
RT @JACCJournals: Are we missing the boat when it comes to using guideline HFrEF meds? https://t.co/9rbFCylt6Q #JACC @UCLAHealth @gcfmd @…
RT @JACCJournals: Are we missing the boat when it comes to using guideline HFrEF meds? https://t.co/9rbFCylt6Q #JACC @UCLAHealth @gcfmd @…
RT @pedschwartzmann: So difficult to achieve the treatment goals for real life patients with #heartfailure ! https://t.co/9NxCFHJmgS
RT @gcfmd: Vital opportunity to improve use and dosing of GDMT for HFrEF. Medical Therapy for Heart Failure With Reduced Ejection Fraction…
RT @SJGreene_md: In current US outpatient practice, there remain major gaps in use & dosing of proven #HFrEF medications. An important oppo…
RT @JTLLERGO: Significant gaps in use and dose of guideline-directed medical therapy in a contemporary outpatient HFrEF registry (The CHAMP…
RT @JACCJournals: Are we missing the boat when it comes to using guideline HFrEF meds? https://t.co/9rbFCylt6Q #JACC @UCLAHealth @gcfmd @…
RT @JACCJournals: Are we missing the boat when it comes to using guideline HFrEF meds? https://t.co/9rbFCylt6Q #JACC @UCLAHealth @gcfmd @…
RT @JACCJournals: Are we missing the boat when it comes to using guideline HFrEF meds? https://t.co/9rbFCylt6Q #JACC @UCLAHealth @gcfmd @…
RT @JACCJournals: Are we missing the boat when it comes to using guideline HFrEF meds? https://t.co/9rbFCylt6Q #JACC @UCLAHealth @gcfmd @…
RT @pedschwartzmann: So difficult to achieve the treatment goals for real life patients with #heartfailure ! https://t.co/9NxCFHJmgS
RT @JACCJournals: Are we missing the boat when it comes to using guideline HFrEF meds? https://t.co/9rbFCylt6Q #JACC @UCLAHealth @gcfmd @…
RT @JACCJournals: Are we missing the boat when it comes to using guideline HFrEF meds? https://t.co/9rbFCylt6Q #JACC @UCLAHealth @gcfmd @…
RT @JACCJournals: Are we missing the boat when it comes to using guideline HFrEF meds? https://t.co/9rbFCylt6Q #JACC @UCLAHealth @gcfmd @…
RT @JACCJournals: Are we missing the boat when it comes to using guideline HFrEF meds? https://t.co/9rbFCylt6Q #JACC @UCLAHealth @gcfmd @…
RT @SJGreene_md: In current US outpatient practice, there remain major gaps in use & dosing of proven #HFrEF medications. An important oppo…
RT @SJGreene_md: In current US outpatient practice, there remain major gaps in use & dosing of proven #HFrEF medications. An important oppo…
RT @SJGreene_md: In current US outpatient practice, there remain major gaps in use & dosing of proven #HFrEF medications. An important oppo…
RT @JACCJournals: Are we missing the boat when it comes to using guideline HFrEF meds? https://t.co/9rbFCylt6Q #JACC @UCLAHealth @gcfmd @…
RT @SJGreene_md: In current US outpatient practice, there remain major gaps in use & dosing of proven #HFrEF medications. An important oppo…
Medical Tx for HF with Reduced EF (CHAMP-HF Registry) https://t.co/EwNe95JfdI https://t.co/LWKUNpOypf
RT @JACCJournals: Are we missing the boat when it comes to using guideline HFrEF meds? https://t.co/9rbFCylt6Q #JACC @UCLAHealth @gcfmd @…
RT @SJGreene_md: In current US outpatient practice, there remain major gaps in use & dosing of proven #HFrEF medications. An important oppo…
RT @JACCJournals: Are we missing the boat when it comes to using guideline HFrEF meds? https://t.co/9rbFCylt6Q #JACC @UCLAHealth @gcfmd @…
RT @JACCJournals: Are we missing the boat when it comes to using guideline HFrEF meds? https://t.co/9rbFCylt6Q #JACC @UCLAHealth @gcfmd @…
RT @ATRIUMRx: Disconcerting results from CHAMP-HF: in patients with HFrEF (and no contraindications to therapies), 27%, 33%, and 67% were…
RT @gcfmd: Vital opportunity to improve use and dosing of GDMT for HFrEF. Medical Therapy for Heart Failure With Reduced Ejection Fraction…
RT @ATRIUMRx: Disconcerting results from CHAMP-HF: in patients with HFrEF (and no contraindications to therapies), 27%, 33%, and 67% were…
RT @ATRIUMRx: Disconcerting results from CHAMP-HF: in patients with HFrEF (and no contraindications to therapies), 27%, 33%, and 67% were…
RT @SJGreene_md: In current US outpatient practice, there remain major gaps in use & dosing of proven #HFrEF medications. An important oppo…
RT @gcfmd: Vital opportunity to improve use and dosing of GDMT for HFrEF. Medical Therapy for Heart Failure With Reduced Ejection Fraction…
RT @pedschwartzmann: So difficult to achieve the treatment goals for real life patients with #heartfailure ! https://t.co/9NxCFHJmgS
RT @SJGreene_md: In current US outpatient practice, there remain major gaps in use & dosing of proven #HFrEF medications. An important oppo…
RT @SJGreene_md: In current US outpatient practice, there remain major gaps in use & dosing of proven #HFrEF medications. An important oppo…
RT @JTLLERGO: Significant gaps in use and dose of guideline-directed medical therapy in a contemporary outpatient HFrEF registry (The CHAMP…
Disconcerting results from CHAMP-HF: in patients with HFrEF (and no contraindications to therapies), 27%, 33%, and 67% were not on ACEI/ARB/ARNI, beta-blocker, and MRA therapy, respectively. Only 1% of eligible patients were on all 3 guideline-recommended
RT @SJGreene_md: In current US outpatient practice, there remain major gaps in use & dosing of proven #HFrEF medications. An important oppo…
RT @SJGreene_md: In current US outpatient practice, there remain major gaps in use & dosing of proven #HFrEF medications. An important oppo…
RT @JACCJournals: Are we missing the boat when it comes to using guideline HFrEF meds? https://t.co/9rbFCylt6Q #JACC @UCLAHealth @gcfmd @…
RT @JTLLERGO: Significant gaps in use and dose of guideline-directed medical therapy in a contemporary outpatient HFrEF registry (The CHAMP…
Significant gaps in use and dose of guideline-directed medical therapy in a contemporary outpatient HFrEF registry (The CHAMP-HF Registry) @JACCJournals @secardiologia @SACardiologia https://t.co/kSG0wwP6Vw https://t.co/y4EbwFk2TP
So difficult to achieve the treatment goals for real life patients with #heartfailure ! https://t.co/9NxCFHJmgS